author_facet Jia, Gai‐Li
Huang, Qi
Cao, Yan‐Nan
Xie, Ci‐Shan
Shen, Yu‐Jing
Chen, Jia‐Li
Lu, Jia‐Hui
Zhang, Mao‐Biao
Li, Jun
Tao, Yuan‐Xiang
Cao, Hong
Jia, Gai‐Li
Huang, Qi
Cao, Yan‐Nan
Xie, Ci‐Shan
Shen, Yu‐Jing
Chen, Jia‐Li
Lu, Jia‐Hui
Zhang, Mao‐Biao
Li, Jun
Tao, Yuan‐Xiang
Cao, Hong
author Jia, Gai‐Li
Huang, Qi
Cao, Yan‐Nan
Xie, Ci‐Shan
Shen, Yu‐Jing
Chen, Jia‐Li
Lu, Jia‐Hui
Zhang, Mao‐Biao
Li, Jun
Tao, Yuan‐Xiang
Cao, Hong
spellingShingle Jia, Gai‐Li
Huang, Qi
Cao, Yan‐Nan
Xie, Ci‐Shan
Shen, Yu‐Jing
Chen, Jia‐Li
Lu, Jia‐Hui
Zhang, Mao‐Biao
Li, Jun
Tao, Yuan‐Xiang
Cao, Hong
Journal of Cellular Physiology
Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
Cell Biology
Clinical Biochemistry
Physiology
author_sort jia, gai‐li
spelling Jia, Gai‐Li Huang, Qi Cao, Yan‐Nan Xie, Ci‐Shan Shen, Yu‐Jing Chen, Jia‐Li Lu, Jia‐Hui Zhang, Mao‐Biao Li, Jun Tao, Yuan‐Xiang Cao, Hong 0021-9541 1097-4652 Wiley Cell Biology Clinical Biochemistry Physiology http://dx.doi.org/10.1002/jcp.29106 <jats:title>Abstract</jats:title><jats:p>This study aims to determine whether caveolin‐1 (Cav‐1) participates in the process of diabetic neuropathic pain by directly regulating the expression of toll‐like receptor 4 (TLR4) and the subsequent phosphorylation of N‐methyl‐D‐aspartate receptor 2B subunit (NR2B) in the spinal cord. Male Sprague‐Dawley rats (120–150 g) were continuously fed with high‐fat and high‐sugar diet for 8 weeks, and received a single low‐dose of intraperitoneal streptozocin injection in preparation for the type‐II diabetes model. Then, these rats were divided into five groups according to the level of blood glucose, and the mechanical withdrawal threshold and thermal withdrawal latency values. The pain thresholds were measured at 3, 7, and 14 days after animal grouping. Then, eight rats were randomly chosen from each group and killed. Lumbar segments 4–6 of the spinal cord were removed for western blot analysis and immunofluorescence assay. Cav‐1 was persistently upregulated in the spinal cord after diabetic neuropathic pain in rats. The downregulation of Cav‐1 through the subcutaneous injection of Cav‐1 inhibitor daidzein ameliorated the pain hypersensitivity and TLR4 expression in the spinal cord in diabetic neuropathic pain (DNP) rats. Furthermore, it was found that Cav‐1 directly bound with TLR4, and the subsequent phosphorylation of NR2B in the spinal cord contributed to the modulation of DNP. These findings suggest that Cav‐1 plays a vital role in DNP processing at least in part by directly regulating the expression of TLR4, and through the subsequent phosphorylation of NR2B in the spinal cord.</jats:p> Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway Journal of Cellular Physiology
doi_str_mv 10.1002/jcp.29106
facet_avail Online
finc_class_facet Biologie
Medizin
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9qY3AuMjkxMDY
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9qY3AuMjkxMDY
institution DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Rs1
DE-Pl11
DE-105
DE-14
DE-Ch1
DE-L229
imprint Wiley, 2020
imprint_str_mv Wiley, 2020
issn 0021-9541
1097-4652
issn_str_mv 0021-9541
1097-4652
language English
mega_collection Wiley (CrossRef)
match_str jia2020cav1participatesinthedevelopmentofdiabeticneuropathypainthroughthetlr4signalingpathway
publishDateSort 2020
publisher Wiley
recordtype ai
record_format ai
series Journal of Cellular Physiology
source_id 49
title Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
title_unstemmed Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
title_full Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
title_fullStr Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
title_full_unstemmed Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
title_short Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
title_sort cav‐1 participates in the development of diabetic neuropathy pain through the tlr4 signaling pathway
topic Cell Biology
Clinical Biochemistry
Physiology
url http://dx.doi.org/10.1002/jcp.29106
publishDate 2020
physical 2060-2070
description <jats:title>Abstract</jats:title><jats:p>This study aims to determine whether caveolin‐1 (Cav‐1) participates in the process of diabetic neuropathic pain by directly regulating the expression of toll‐like receptor 4 (TLR4) and the subsequent phosphorylation of N‐methyl‐D‐aspartate receptor 2B subunit (NR2B) in the spinal cord. Male Sprague‐Dawley rats (120–150 g) were continuously fed with high‐fat and high‐sugar diet for 8 weeks, and received a single low‐dose of intraperitoneal streptozocin injection in preparation for the type‐II diabetes model. Then, these rats were divided into five groups according to the level of blood glucose, and the mechanical withdrawal threshold and thermal withdrawal latency values. The pain thresholds were measured at 3, 7, and 14 days after animal grouping. Then, eight rats were randomly chosen from each group and killed. Lumbar segments 4–6 of the spinal cord were removed for western blot analysis and immunofluorescence assay. Cav‐1 was persistently upregulated in the spinal cord after diabetic neuropathic pain in rats. The downregulation of Cav‐1 through the subcutaneous injection of Cav‐1 inhibitor daidzein ameliorated the pain hypersensitivity and TLR4 expression in the spinal cord in diabetic neuropathic pain (DNP) rats. Furthermore, it was found that Cav‐1 directly bound with TLR4, and the subsequent phosphorylation of NR2B in the spinal cord contributed to the modulation of DNP. These findings suggest that Cav‐1 plays a vital role in DNP processing at least in part by directly regulating the expression of TLR4, and through the subsequent phosphorylation of NR2B in the spinal cord.</jats:p>
container_issue 3
container_start_page 2060
container_title Journal of Cellular Physiology
container_volume 235
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792346687716458504
geogr_code not assigned
last_indexed 2024-03-01T17:43:11.484Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Cav%E2%80%901+participates+in+the+development+of+diabetic+neuropathy+pain+through+the+TLR4+signaling+pathway&rft.date=2020-03-01&genre=article&issn=1097-4652&volume=235&issue=3&spage=2060&epage=2070&pages=2060-2070&jtitle=Journal+of+Cellular+Physiology&atitle=Cav%E2%80%901+participates+in+the+development+of+diabetic+neuropathy+pain+through+the+TLR4+signaling+pathway&aulast=Cao&aufirst=Hong&rft_id=info%3Adoi%2F10.1002%2Fjcp.29106&rft.language%5B0%5D=eng
SOLR
_version_ 1792346687716458504
author Jia, Gai‐Li, Huang, Qi, Cao, Yan‐Nan, Xie, Ci‐Shan, Shen, Yu‐Jing, Chen, Jia‐Li, Lu, Jia‐Hui, Zhang, Mao‐Biao, Li, Jun, Tao, Yuan‐Xiang, Cao, Hong
author_facet Jia, Gai‐Li, Huang, Qi, Cao, Yan‐Nan, Xie, Ci‐Shan, Shen, Yu‐Jing, Chen, Jia‐Li, Lu, Jia‐Hui, Zhang, Mao‐Biao, Li, Jun, Tao, Yuan‐Xiang, Cao, Hong, Jia, Gai‐Li, Huang, Qi, Cao, Yan‐Nan, Xie, Ci‐Shan, Shen, Yu‐Jing, Chen, Jia‐Li, Lu, Jia‐Hui, Zhang, Mao‐Biao, Li, Jun, Tao, Yuan‐Xiang, Cao, Hong
author_sort jia, gai‐li
container_issue 3
container_start_page 2060
container_title Journal of Cellular Physiology
container_volume 235
description <jats:title>Abstract</jats:title><jats:p>This study aims to determine whether caveolin‐1 (Cav‐1) participates in the process of diabetic neuropathic pain by directly regulating the expression of toll‐like receptor 4 (TLR4) and the subsequent phosphorylation of N‐methyl‐D‐aspartate receptor 2B subunit (NR2B) in the spinal cord. Male Sprague‐Dawley rats (120–150 g) were continuously fed with high‐fat and high‐sugar diet for 8 weeks, and received a single low‐dose of intraperitoneal streptozocin injection in preparation for the type‐II diabetes model. Then, these rats were divided into five groups according to the level of blood glucose, and the mechanical withdrawal threshold and thermal withdrawal latency values. The pain thresholds were measured at 3, 7, and 14 days after animal grouping. Then, eight rats were randomly chosen from each group and killed. Lumbar segments 4–6 of the spinal cord were removed for western blot analysis and immunofluorescence assay. Cav‐1 was persistently upregulated in the spinal cord after diabetic neuropathic pain in rats. The downregulation of Cav‐1 through the subcutaneous injection of Cav‐1 inhibitor daidzein ameliorated the pain hypersensitivity and TLR4 expression in the spinal cord in diabetic neuropathic pain (DNP) rats. Furthermore, it was found that Cav‐1 directly bound with TLR4, and the subsequent phosphorylation of NR2B in the spinal cord contributed to the modulation of DNP. These findings suggest that Cav‐1 plays a vital role in DNP processing at least in part by directly regulating the expression of TLR4, and through the subsequent phosphorylation of NR2B in the spinal cord.</jats:p>
doi_str_mv 10.1002/jcp.29106
facet_avail Online
finc_class_facet Biologie, Medizin, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9qY3AuMjkxMDY
imprint Wiley, 2020
imprint_str_mv Wiley, 2020
institution DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229
issn 0021-9541, 1097-4652
issn_str_mv 0021-9541, 1097-4652
language English
last_indexed 2024-03-01T17:43:11.484Z
match_str jia2020cav1participatesinthedevelopmentofdiabeticneuropathypainthroughthetlr4signalingpathway
mega_collection Wiley (CrossRef)
physical 2060-2070
publishDate 2020
publishDateSort 2020
publisher Wiley
record_format ai
recordtype ai
series Journal of Cellular Physiology
source_id 49
spelling Jia, Gai‐Li Huang, Qi Cao, Yan‐Nan Xie, Ci‐Shan Shen, Yu‐Jing Chen, Jia‐Li Lu, Jia‐Hui Zhang, Mao‐Biao Li, Jun Tao, Yuan‐Xiang Cao, Hong 0021-9541 1097-4652 Wiley Cell Biology Clinical Biochemistry Physiology http://dx.doi.org/10.1002/jcp.29106 <jats:title>Abstract</jats:title><jats:p>This study aims to determine whether caveolin‐1 (Cav‐1) participates in the process of diabetic neuropathic pain by directly regulating the expression of toll‐like receptor 4 (TLR4) and the subsequent phosphorylation of N‐methyl‐D‐aspartate receptor 2B subunit (NR2B) in the spinal cord. Male Sprague‐Dawley rats (120–150 g) were continuously fed with high‐fat and high‐sugar diet for 8 weeks, and received a single low‐dose of intraperitoneal streptozocin injection in preparation for the type‐II diabetes model. Then, these rats were divided into five groups according to the level of blood glucose, and the mechanical withdrawal threshold and thermal withdrawal latency values. The pain thresholds were measured at 3, 7, and 14 days after animal grouping. Then, eight rats were randomly chosen from each group and killed. Lumbar segments 4–6 of the spinal cord were removed for western blot analysis and immunofluorescence assay. Cav‐1 was persistently upregulated in the spinal cord after diabetic neuropathic pain in rats. The downregulation of Cav‐1 through the subcutaneous injection of Cav‐1 inhibitor daidzein ameliorated the pain hypersensitivity and TLR4 expression in the spinal cord in diabetic neuropathic pain (DNP) rats. Furthermore, it was found that Cav‐1 directly bound with TLR4, and the subsequent phosphorylation of NR2B in the spinal cord contributed to the modulation of DNP. These findings suggest that Cav‐1 plays a vital role in DNP processing at least in part by directly regulating the expression of TLR4, and through the subsequent phosphorylation of NR2B in the spinal cord.</jats:p> Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway Journal of Cellular Physiology
spellingShingle Jia, Gai‐Li, Huang, Qi, Cao, Yan‐Nan, Xie, Ci‐Shan, Shen, Yu‐Jing, Chen, Jia‐Li, Lu, Jia‐Hui, Zhang, Mao‐Biao, Li, Jun, Tao, Yuan‐Xiang, Cao, Hong, Journal of Cellular Physiology, Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway, Cell Biology, Clinical Biochemistry, Physiology
title Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
title_full Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
title_fullStr Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
title_full_unstemmed Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
title_short Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
title_sort cav‐1 participates in the development of diabetic neuropathy pain through the tlr4 signaling pathway
title_unstemmed Cav‐1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway
topic Cell Biology, Clinical Biochemistry, Physiology
url http://dx.doi.org/10.1002/jcp.29106